These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 25329461)

  • 41. Genetic Polymorphisms within Interferon-λ Region and Interferon-λ3 in the Human Pathophysiology: Their Contribution to Outcome, Treatment, and Prevention of Infections with Hepatotropic Viruses.
    Grzegorzewska AE
    Curr Med Chem; 2019; 26(25):4832-4851. PubMed ID: 30027841
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Association of HLA-DQ and IFNL4 polymorphisms with hepatitis B virus infection and clearance].
    Chen H; Fan JH; Chen WX; Guo JJ; Huang Y
    Zhonghua Gan Zang Bing Za Zhi; 2017 Jul; 25(7):506-511. PubMed ID: 29055988
    [No Abstract]   [Full Text] [Related]  

  • 43. A Knockout IFNL4 Variant Is Associated With Protection From Sexually Transmitted HIV-1 Infection.
    Jaimes-Bernal C; Rallón N; Benito JM; Omar M; Gómez-Vidal MA; Márquez FJ; Sánchez-Arcas B; Trujillo M; Royo JL; Saulle I; Biasin M; Rivero-Juárez A; Caruz A
    J Infect Dis; 2019 Feb; 219(5):772-776. PubMed ID: 30289470
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Association between variants in the interferon lambda 4 locus and substitutions in the hepatitis C virus non-structural protein 5A.
    Akamatsu S; Hayes CN; Ochi H; Uchida T; Kan H; Murakami E; Abe H; Tsuge M; Miki D; Akiyama R; Hiraga N; Imamura M; Aikata H; Kawaoka T; Kawakami Y; Chayama K
    J Hepatol; 2015 Sep; 63(3):554-63. PubMed ID: 25849245
    [TBL] [Abstract][Full Text] [Related]  

  • 45. IFN-λ4 desensitizes the response to IFN-α treatment in chronic hepatitis C through long-term induction of USP18.
    Fan W; Xie S; Zhao X; Li N; Chang C; Li L; Yu G; Chi X; Pan Y; Niu J; Zhong J; Sun B
    J Gen Virol; 2016 Sep; 97(9):2210-2220. PubMed ID: 27302182
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Interferon lambda 4 genotypes and resistance-associated variants in patients infected with hepatitis C virus genotypes 1 and 3.
    Peiffer KH; Sommer L; Susser S; Vermehren J; Herrmann E; Döring M; Dietz J; Perner D; Berkowski C; Zeuzem S; Sarrazin C
    Hepatology; 2016 Jan; 63(1):63-73. PubMed ID: 26406534
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Comparative Functional Analysis of 12 Mammalian IFN-λ4 Orthologs.
    Paquin A; Onabajo OO; Tang W; Prokunina-Olsson L
    J Interferon Cytokine Res; 2016 Jan; 36(1):30-6. PubMed ID: 26308395
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The impact of genetic variation in IL28B, IFNL4 and HLA genes on treatment responses against chronic hepatitis C virus infection.
    Sakhaee F; Ghazanfari M; Vaziri F; Jamnani FR; Davari M; Gharibzadeh S; Fateh R; Abdolrahimi F; Dizaji SP; Fateh A; Siadat SD
    Infect Genet Evol; 2017 Oct; 54():330-337. PubMed ID: 28739427
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Lymphocytes degranulation in liver in hepatitis C virus carriers is associated with IFNL4 polymorphisms and ALT levels.
    Jouvin-Marche E; Macek Jílková Z; Thelu MA; Marche H; Fugier E; Van Campenhout N; Hoang XS; Marlu A; Sturm N; Callanan M; Leroy V; Zarski JP; Marche PN
    J Infect Dis; 2014 Jun; 209(12):1907-15. PubMed ID: 24415789
    [TBL] [Abstract][Full Text] [Related]  

  • 50. IFNL4 rs368234815 and rs117648444 variants predict off-treatment HBsAg seroclearance in IFN-treated HBeAg-negative chronic hepatitis B patients.
    Galmozzi E; Facchetti F; Grossi G; Loglio A; Viganò M; Lunghi G; Colombo M; Lampertico P
    Liver Int; 2018 Mar; 38(3):417-423. PubMed ID: 28732143
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Gender-dependent multiple cross-phenotype association of interferon lambda genetic variants with peripheral blood profiles in healthy individuals.
    Roy DG; Singh L; Chaturvedi HK; Chinnaswamy S
    Mol Genet Genomic Med; 2024 Jan; 12(1):e2292. PubMed ID: 37795763
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A variant upstream of IFNL3 (IL28B) creating a new interferon gene IFNL4 is associated with impaired clearance of hepatitis C virus.
    Prokunina-Olsson L; Muchmore B; Tang W; Pfeiffer RM; Park H; Dickensheets H; Hergott D; Porter-Gill P; Mumy A; Kohaar I; Chen S; Brand N; Tarway M; Liu L; Sheikh F; Astemborski J; Bonkovsky HL; Edlin BR; Howell CD; Morgan TR; Thomas DL; Rehermann B; Donnelly RP; O'Brien TR
    Nat Genet; 2013 Feb; 45(2):164-71. PubMed ID: 23291588
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The impact of natural selection on an ABCC11 SNP determining earwax type.
    Ohashi J; Naka I; Tsuchiya N
    Mol Biol Evol; 2011 Jan; 28(1):849-57. PubMed ID: 20937735
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The influence of admixture and consanguinity on population genetic diversity in Middle East.
    Yang X; Al-Bustan S; Feng Q; Guo W; Ma Z; Marafie M; Jacob S; Al-Mulla F; Xu S
    J Hum Genet; 2014 Nov; 59(11):615-22. PubMed ID: 25253659
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Interferon lambda 4 gene polymorphisms as a predicting tool of response to hepatitis C virus genotype 4 patients treated with Sofosbuvir and Ribavirin.
    Sakr AA; Ahmed AE; Abd El-Maksoud MDE; Gamal A; El-Garem H; Ahmed OM
    Infect Genet Evol; 2020 Dec; 86():104606. PubMed ID: 33127459
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Evidence for Very Recent Positive Selection in Mongolians.
    Nakayama K; Ohashi J; Watanabe K; Munkhtulga L; Iwamoto S
    Mol Biol Evol; 2017 Aug; 34(8):1936-1946. PubMed ID: 28444381
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Diversification of the ADH1B gene during expansion of modern humans.
    Li H; Gu S; Han Y; Xu Z; Pakstis AJ; Jin L; Kidd JR; Kidd KK
    Ann Hum Genet; 2011 Jul; 75(4):497-507. PubMed ID: 21592108
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Population Polymorphism of IFNL3 and IFNL4 Genes of Type 3 Interferon Associated with Spontaneous Clearance of Hepatitis C Virus in Representatives of Caucasian and Mongoloid Races.
    Malov IV; Malov SI; Savilov ED; Gantulga D; Stepanenko LA; Ogarkov OB; Nyamkhuu D; Aitov KA; Nyamdawa P; Kolesnikov SI
    Bull Exp Biol Med; 2016 Jul; 161(3):404-7. PubMed ID: 27492404
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Association of the IFNL4-ΔG Allele With Impaired Spontaneous Clearance of Hepatitis C Virus.
    Aka PV; Kuniholm MH; Pfeiffer RM; Wang AS; Tang W; Chen S; Astemborski J; Plankey M; Villacres MC; Peters MG; Desai S; Seaberg EC; Edlin BR; Strickler HD; Thomas DL; Prokunina-Olsson L; Sharp GB; O'Brien TR
    J Infect Dis; 2014 Feb; 209(3):350-4. PubMed ID: 23956438
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The role of IFNL4 in liver inflammation and progression of fibrosis.
    Møhlenberg M; O'Brien TR; Hartmann R
    Genes Immun; 2022 Jun; 23(3-4):111-117. PubMed ID: 35585257
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.